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Bone mineralization in prepuber tal children with cystic fibrosis 
C. B onnemains 1, E. Dar viot 1, F. Tr oussier 1, T. Urban 1, M. Audr ala 9, J.L. Gini6s 1 
ICRCM, 2Service de rhumatologie, CHU, Anger~, France 
Osleoporosis and osteopenia re frequently seen in cystic fibrosis. Most studies 
have fc~used on adolescents or adults, and a delay in puberty is considered to be one 
of the factors accounting for these abnormalities in bone mineralization. Our study 
thus investigated the quality of bone mineral ization in prepuber tal children with this 
disease. 
The study was retrospective: lumbar bone density was measured by a dual energy 
X~ay densit ometer (biologic QDR 3(~))  in 21 children with cystic fibrosis, 14 girls 
mad 7 boys. At the t ime of the measurements, he ages ranged from 6 to 10 years. 
The chi ldren's weight /height  ratio was 97+9% (77 to 112). Their global 
Schwachman score was 86+7 (72 to 94). None of them were pubertal. 
The remits were as follows: the mean Z score for lumbar bone density was 91 +11% 
(59 to 109), significantly different from the normal values for their age (p<0.001). 
Four children had Z scores between the mean mad +ISD, 9 had scores between the 
mean mad 1 SD, 7 between 1 and 2 SD, mad 1 had a score below 2 SD. 
Our results show that abnormalities in bone density may appear as early as 6 years 
of age ha children with cystic fibrosis. These abnormalities must be detected as early 
as possible before the age of puberty and may require specific management even at 
a y oung age. 
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Bone Mineral Content in Children and Adolescents with CF 
T.M. Snow 1, M.J. Pierrpoint 1,J. Lowden 2, I.J. Doul l  2 
~Department of ChiM Health, NevilI Hall Hospital, Abergavenny and 2ChiMren's 
Hospital for Wales, Cardiff, Wales, UK 
Aims:  To determine the bone mineral density of a cohort of children mad 
adolescents with cystic fibrosis 
Methods:  Cross sectional analysis of subjects reviewed by the Welsh regional CF 
centre ha Cardiff. A l l  subjects had bone mineral  content measured by Hologic QDR 
l(~)tNV bone densitometer, and results standardised to a control population of 50 
healthy volunteers age 6 18 years to generate bone mineral content (BMC) standard 
deviation scores (SDS) for total hip (TH) and lumbar spine (LS) for each subject. 
Results: 89 CF subjects (43 F) of mean (SD) age 12.3 (3.6) years of whom 41 were 
prepubertal. Mean (SD) BMC SDS LS was 4).16 and 1TI was 0.29. For TH 3 
patients had SDS > 1.5 and4 SDS > 2.0, whi le  3 had SDS > +1.5 and 3 >+2.0. In 
contrast 6 subjects had LS SDS > 1.5 and 6 SDS > 2.0, whi le  3 had SDS > +1.5 mad 
3 >+2.0. 
Conclusion: Although affects LS BMC more than ~I  BMC, ha a population of 
older children and adolescents results are not mbstantial ly different o a normal 
population. 
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Alimentary calcium intake by cystic fibrosis patients 
M. Genetello, S. Van Bier vliet, E. Robberecht 
Ghent CF Centre, Dept. Pediatrics, University Hospital, B 9000Ghent, Belgium 
Several factors play an important role in the c~cm~ence of osleopenia and 
osteoporosis in cystic fibrosis (CF) such as vitamin D, hormones, medication mad 
physical activity. A sufficiently high calcium intake is indispensable. To control 
adequacy of dai ly alimentary calcium intake, it was calculated and compared to 
recommendations. 
From retrospective food intake questiommires, the daily calcium intake of 121 CF 
patients was calculated (65 male; age 1 .2Mly ;  mean) 15.9y; median (M) 
16.2 y). Calcium supplements and the calcium content of water were not included. 
Based on the recommended daily l owance of calcium (RDA) from the Belgian 
Health Council, patients were divided ha 4 age groups: A 1 10y (n~40), B 11 14y 
(n 16), C 15 18y (n 22), D>19y (n 43). National recommendations are: A 
8COmg, B l (~)mg,  C 1200mg, D 9COmg. 
Results, expressed as percentage of RDA, are (range, mean, M):  A 39 334 (119, 
115), B 5zi 234 (112, 108), C 31 266 (111, 111), D 27 242 (110, 106) and for the 
total group 27 334 (113, 109). 
Calcium content of the diet was below RDA ha 41% of the total group. Percentage 
of patients taking less than 100% RDA (with their mean, M percentage of RDA): A 
40 (75, 76), B 38 (71, 69), C 41 (62, 68), D 44 (71, 76). Compared to a group of 
healthy 13 18y, the daily average calcium intake of the CF group was higher. 
Conclusion: Compared to the Belgian RDA, 41% of the CF group has an inadequate 
calcium intake. As the American recommendations for children above 8 are even 
higher, more attention should be paid to the dairy consumption. We suggest o 
inform patients on the importance of calcium, learn them their individual needs and 
the rule that 4120 ml  mi lk  delivers 500 mg calcium. To maximize absorption egative 
ilffluences on bioavailabil ity of e.g. steatorhea must be minimized. 
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Risk factors for decreased Bone Mineral Content (BMC) in children 
and adolescents with CF 
J. Lowdon, I.J.M. Doul l  
The ChiMren's Hospital of Wales, Cardiff, Wales, UK 
Aim:  To determine risk factors for decreased BMC in a cross section of children and 
adolescents with CF. 
Method:  Al l  children, over the age of 5 years, attending the Children's Hospital, 
undergo measurement of bone density every two years and yearly i f  on oral steroids. 
Data was collected on respiratory function, antbropometry, disease severity, 
nutritional intake and blood biochemistry. 
Results: Fifty six subjects underwent a bone scan. Mean (SD) age was 11.7 years 
(3.9), 32 male. Mean weight SDS was 0.02 (1.2), mean height SDS =:).5 (1.2) and 
mean BMI  SDS 0.3 (1.3), mean FEV1% predicted 83% (22.2) mean FVC 85% 
predicted (19.5), mean Shwacman Score was 77 (18.1) and mean Cbrispin Norman 
Score was 8 (SD 3.2). Two patients measured below the lowest reference range for 
total hip (TH) and lumbar spine (LS). BMC of LS was significantly lower in the 
patients receiving oral corticosteroids than those who were not ( 1.22 (0.65) vs 
=:).07 (1.02); mean dill" 1.15; 95% CI diff  0.34, 1.94; p 0.006). BMC of TH was 
significantly lower ha females compared to males ~0.75  vs 0.05, mean diff  0.03; 
95% CI di l f  0.6, 0.5, p 0.022). 
Conclusion: Our results suggest that osleopenia/osteoporosis is not a typical 
f inding in wel l  nourished, mildly affected children mad adolescents with CF. In this 
cohort of patients, oral steroids were the only significant factor that could predict 
the decrease in bone mineralisation. 
